Clinical trial
A Multi-center, Double-blind, Randomized, Placebo-controlled Study of TT223 in Patients With Type 2 Diabetes Treated With Metformin and/or TZD
NCT00743002 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Double-blind, Randomized, Placebo-controlled Study of TT223 in Patients With Type 2 Diabetes Treated With Metformin and/or TZD
- Lead sponsor
- OPKO Health, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2008
- Completion date
- December 31, 2009
- Enrollment
- 87 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.